| 1 | 5 ASA, enemas, suppositories, corticosteroids | - | - | - | - | 1件: 97 97 |
| 2 | ACEI/ARB and corticosteroids | - | - | - | - | 1件: 66 66 |
| 3 | Azithromycin + N-acetylcystein + inhaled corticosteroid | 1件: Azithromycin Azithromycin | 2件: D06390
D06390
,
D07486
| - | - | 1件: 228 228 |
| 4 | Chronic Corticosteroid Therapy | - | - | - | - | 1件: 113 113 |
| 5 | Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 85 85 |
| 6 | Corticosteroid | - | - | - | - | 9件: 13 13, 42, 43, 44, 45, 66, 96, 97, 222 |
| 7 | Corticosteroid (CS) | - | - | - | - | 1件: 41 41 |
| 8 | Corticosteroid and azathioprine | 1件: Azathioprine Azathioprine | 1件: D00238
D00238
| - | - | 4件: 42 42, 43, 44, 45 |
| 9 | Corticosteroid and non-biological agents. | - | - | - | - | 1件: 46 46 |
| 10 | Corticosteroid or NSAID | - | - | - | - | 1件: 46 46 |
| 11 | Corticosteroid treatment (Methylprednisolone or prednisolone) | 2件: Methylprednisolone Methylprednisolone,
Prednisolone | 2件: D00407
D00407
,
D00472
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 64 64 |
| 12 | Corticosteroids | - | - | - | - | 12件: 41 41, 46, 49, 63, 64, 97, 107, 113, 164, 220, 296, 300 |
| 13 | Corticosteroids & tanCART19/20 | - | - | - | - | 1件: 13 13 |
| 14 | Corticosteroids (Aprednislon) | - | - | - | - | 1件: 63 63 |
| 15 | Corticosteroids (prednisone or prednisolone) | 2件: Prednisolone Prednisolone,
Prednisone | 2件: D00472
D00472
,
D00473
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 49 49 |
| 16 | Corticosteroids +immune suppressive +amino salicylic acid | 1件: Salicylic acid Salicylic acid | 1件: D00097
D00097
| - | - | 1件: 97 97 |
| 17 | Corticosteroids for Systemic Use | - | - | - | - | 1件: 41 41 |
| 18 | Corticosteroids only | - | - | - | - | 1件: 97 97 |
| 19 | Corticosteroids'therapy | - | - | - | - | 1件: 35 35 |
| 20 | CS (corticosteroids) Only | - | - | - | - | 1件: 97 97 |
| 21 | Cumulative corticosteroid exposure | - | - | - | - | 1件: 49 49 |
| 22 | H02 - Corticosteroidi Sistemici | - | - | - | - | 1件: 299 299 |
| 23 | Intra-articular corticosteroid injection | - | - | - | - | 1件: 46 46 |
| 24 | IV Corticosteroid | - | - | - | - | 1件: 97 97 |
| 25 | Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolone | 2件: Mesalazine Mesalazine,
Methylprednisolone | 2件: D00377
D00377
,
D00407
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
| 26 | Oral corticosteroids | - | - | - | - | 5件: 13 13, 46, 97, 171, 251 |
| 27 | Oral corticosteroids (OCS) | - | - | - | - | 1件: 162 162 |
| 28 | Prophylactic Corticosteroid Taper Regimen | - | - | - | - | 1件: 251 251 |
| 29 | Reactive Corticosteroid Taper Regimen | - | - | - | - | 1件: 251 251 |
| 30 | Rituximab, Cyclophosphamide, and Corticosteroids | 2件: Cyclophosphamide Cyclophosphamide,
Rituximab | 3件: D00287
D00287
,
D02994
,
D07760
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 222 222 |
| 31 | Treatment with topical superpotent corticosteroid therapy | - | - | - | - | 1件: 162 162 |
| 32 | Valproid acid plus corticosteroids | - | - | - | - | 1件: 26 26 |